Cargando…
Improved Synthesis and Isolation of Bedaquiline
[Image: see text] Bedaquiline (BDQ) is the most critical pharmaceutical in the world for treating multidrug-resistant Mycobacterium tuberculosis. Despite it being highly effective, BDQ asymmetric synthesis remains a challenge. Herein, the influence of chiral bases, namely, bis(1-phenylethyl)amine, b...
Autores principales: | Lubanyana, Hlengekile, Arvidsson, Per I., Govender, Thavendran, Kruger, Hendrik G., Naicker, Tricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045498/ https://www.ncbi.nlm.nih.gov/pubmed/32118176 http://dx.doi.org/10.1021/acsomega.9b04037 |
Ejemplares similares
-
Correction to “Improved Synthesis and Isolation
of Bedaquiline”
por: Lubanyana, Hlengekile, et al.
Publicado: (2020) -
Bedaquiline has potential for targeting tuberculosis reservoirs in the central nervous system
por: Pamreddy, Annapurna, et al.
Publicado: (2018) -
6,7-Dimethoxy-3-methoxycarbonyl-1-(2-methoxyphenyl)-3,4-dihydroisoquinoline 2-oxide
por: Naicker, Tricia, et al.
Publicado: (2011) -
(1S,3S)-Methyl 6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylate
por: Naicker, Tricia, et al.
Publicado: (2011) -
(1S,3S)-Methyl 2-benzyl-6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylate
por: Naicker, Tricia, et al.
Publicado: (2011)